Drug Type Small molecule drug |
Synonyms GAT-211, GAT211 |
Target |
Action modulators |
Mechanism CB1 modulators(Cannabinoid CB1 receptor modulators) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC22H18N2O2 |
InChIKeyOHZDCJJHWPHZJD-UHFFFAOYSA-N |
CAS Registry102704-40-5 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Huntington Disease | Preclinical | Canada | 30 Mar 2019 | |
Huntington Disease | Preclinical | Canada | 30 Mar 2019 |